| /v1/companies/search | B 75.1 | 99.6% | 1.00 |
| /v1/carriers/search | B 75.0 | 99.2% | 1.00 |
| /v1/feeds/distress-signals | B 75.1 | 99.6% | 1.00 |
| /v1/feeds/carrier-analytics | B 75.3 | 100.0% | 1.00 |
| /v1/stats/companies | B 75.5 | 98.9% | 1.00 |
| /v1/stats/opportunities | B 75.9 | 100.0% | 1.00 |
| /v1/awards/search | B 75.0 | 99.2% | 1.00 |
| /v1/opportunities/search | B 75.3 | 100.0% | 1.00 |
| /v1/stats/sponsors | B 75.5 | 98.9% | 1.00 |
| /v1/sponsors/search | B 75.2 | 99.6% | 1.00 |
| /v1/stats/carriers | B 75.5 | 98.9% | 1.00 |
| /v1/health | B 75.9 | 99.6% | 1.00 |
| /v1/trials/search | B 75.7 | 100.0% | 1.00 |
| /v1/subawards/search | B 75.4 | 99.6% | 1.00 |
| /v1/insiders/transactions | B 75.5 | 99.6% | 1.00 |
| /v1/insiders/clusters | B 75.2 | 99.1% | 1.00 |
| /v1/va/opportunities/search | B 75.5 | 100.0% | 1.00 |
| /v1/va/vendors/search | B 75.6 | 100.0% | 1.00 |
| /v1/va/facilities/search | B 74.9 | 99.1% | 1.00 |
| /v1/fda/recalls/search | B 75.2 | 99.1% | 1.00 |
| /v1/msha/mines/search | B 75.5 | 100.0% | 1.00 |
| /v1/patents/assignees/search | B 75.3 | 99.5% | 1.00 |
| /v1/patents/search | B 75.5 | 100.0% | 1.00 |
| /v1/fsis/recalls/search | B 75.3 | 99.5% | 1.00 |
| /v1/fsis/establishments/search | B 75.5 | 100.0% | 1.00 |
| /v1/trials/sites/search | B 75.4 | 100.0% | 1.00 |
| /v1/fda/device-clearances/search | B 75.2 | 99.5% | 1.00 |
| /v1/fda/drug-approvals/search | B 75.4 | 100.0% | 1.00 |
| /v1/msha/violations/search | B 75.2 | 100.0% | 1.00 |
| /v1/sba/loans/search | B 75.2 | 100.0% | 1.00 |
| /v1/phmsa/incidents/search | B 74.9 | 99.0% | 1.00 |
| /v1/phmsa/operators/search | B 75.3 | 100.0% | 1.00 |
| /v1/faa/deregistrations/search | B 75.2 | 100.0% | 1.00 |
| /v1/faa/aircraft/search | B 74.9 | 99.0% | 1.00 |
| /v1/fcc/licenses/search | B 75.0 | 99.5% | 1.00 |
| /v1/hrsa/mua/search | B 75.0 | 100.0% | 1.00 |
| /v1/hrsa/hpsa/search | B 75.1 | 100.0% | 1.00 |
| /v1/ttb/permittees/search | B 74.9 | 99.5% | 1.00 |
| /v1/nlrb/cases/search | B 75.1 | 100.0% | 1.00 |
| /v1/epa/tri/search | B 75.1 | 100.0% | 1.00 |
| /v1/epa/rcra-handlers/search | B 74.6 | 98.9% | 1.00 |
| /v1/fda/warning-letters/search | B 75.1 | 100.0% | 1.00 |
| /v1/hcris/staffing-decline/search | B 75.1 | 100.0% | 1.00 |
| /v1/feeds/clinical-trials | B 74.3 | 98.3% | 1.00 |
| /v1/feeds/insider-buying | B 74.9 | 100.0% | 1.00 |
| /v1/prescribers/lookup | B 74.9 | 100.0% | 1.00 |
| /v1/feeds/pharma-prescribing | B 74.7 | 99.4% | 1.00 |
| /v1/hcris/cost-reports/search | B 74.7 | 100.0% | 1.00 |
| /v1/cms/timely-care/delta | B 74.9 | 100.0% | 1.00 |
| /v1/cms/timely-care/search | B 74.9 | 100.0% | 1.00 |
| /v1/feeds/labor-petitions | B 74.2 | 98.3% | 1.00 |
| /v1/feeds/sdvosb | B 74.5 | 99.4% | 1.00 |
| /v1/feeds/subawards | B 74.7 | 100.0% | 1.00 |
| /v1/feeds/warning-letters | B 74.7 | 100.0% | 1.00 |
| /v1/feeds/fda-device-clearances | B 74.5 | 99.4% | 1.00 |
| /v1/feeds/fda-drug-approvals | B 74.7 | 100.0% | 1.00 |
| /v1/feeds/sba-loans | B 74.7 | 100.0% | 1.00 |
| /v1/feeds/patent-grants | B 74.2 | 98.8% | 1.00 |
| /v1/feeds/contract-awards | B 74.7 | 100.0% | 1.00 |
| /v1/feeds/rcra-handlers | B 74.4 | 100.0% | 1.00 |
| /v1/pecos/provider-exodus/search | B 74.1 | 100.0% | 0.94 |
| /v1/pecos/enrollment-exodus/search | B 74.0 | 100.0% | 0.94 |
| /v1/pecos/enrollments/search | B 74.1 | 100.0% | 0.94 |